Comparison of Two Rituximab Induction Regimens for Antineutrophil Cytoplasm Antibody-Associated Vasculitis: Systematic Review and Meta-Analysis.
Valérie BénardCynthia FarhatMelissa Zarandi-NowrooziMadeleine DurandPierre CharlesXavier PuechalLoic GuillevinChristian PagnouxJean-Paul MakhzoumPublished in: ACR open rheumatology (2021)
No difference was found in terms of efficacy or safety between the four- and two-dose RTX regimens for induction of remission in severe AAV.